KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sabra Health Care REIT (SBRA) Change in Acquisitions & Divestments (2016 - 2025)

Sabra Health Care REIT (SBRA) has 12 years of Change in Acquisitions & Divestments data on record, last reported at -$11.0 million in Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 409.21% year-over-year to -$11.0 million; the TTM value through Dec 2025 reached $4.5 million, up 25.65%, while the annual FY2025 figure was $4.5 million, 25.65% up from the prior year.
  • Change in Acquisitions & Divestments reached -$11.0 million in Q4 2025 per SBRA's latest filing, down from $8.4 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $8.4 million in Q3 2025 and bottomed at -$11.0 million in Q4 2025.
  • Average Change in Acquisitions & Divestments over 5 years is $1.3 million, with a median of $662000.0 recorded in 2021.
  • The widest YoY moves for Change in Acquisitions & Divestments: up 805.97% in 2025, down 409.21% in 2025.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $517000.0 in 2021, then decreased by 25.15% to $387000.0 in 2022, then soared by 55.04% to $600000.0 in 2023, then surged by 491.83% to $3.6 million in 2024, then plummeted by 409.21% to -$11.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were -$11.0 million in Q4 2025, $8.4 million in Q3 2025, and $5.9 million in Q2 2025.